CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
1995 · The Journal of Cell Biology · 429 citations
https://doi.org/10.1083/jcb.128.4.687
D
David G. Jackson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
444
Papers
38.8K
Citations
101
h-index
260
i10-index
David G. Jackson is an academic researcher from Huazhong Agricultural University. The author has contributed to research in topics: Lymphatic System and Diseases & Proteoglycans and glycosaminoglycans research & Angiogenesis and VEGF in Cancer. The author has an h-index of 101, co-authored 378 publications.
Papers by this author
worksLYVE-1, the lymphatic system and tumor lymphangiogenesis
2001 · Trends in Immunology · 355 citations
https://doi.org/10.1016/s1471-4906(01)01936-6
Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation.
1990 · The Journal of Immunology · 346 citations
https://doi.org/10.4049/jimmunol.144.7.2811
Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
1995 · The Journal of Cell Biology · 251 citations
https://doi.org/10.1083/jcb.128.4.673
Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia
2004 · British Journal of Cancer · 210 citations
https://doi.org/10.1038/sj.bjc.6601727
Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization
2016 · Journal of Biological Chemistry · 128 citations
https://doi.org/10.1074/jbc.m115.708305
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat